SynAct Pharma AB: ifrs:EquityAttributableToOwnersOfParent
| Value | {"amount": 126520000.0} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | SynAct Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:56:10.380701+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/612aa090-7479-4616-ac80-597a1a17f3b5
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:549300RRYIEFEQ72N546:2023-12-31Retrieved: 2026-08-23T23:56:10.380701+02:00
Raw response sha256:
c6bdc5c5472ae13ac80f56093c8f1d77…Cite as: FACTANKER, https://factanker.com/fact/612aa090-7479-4616-ac80-597a1a17f3b5
History
- no predecessors — first report